Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Atossa Therapeutics, Inc. (ATOS.MX)

Mexico - Mexico Delayed Price. Currency in MXN
14.00-0.74 (-5.02%)
At close: 12:56PM CST
Advertisement
Advertisement
Show:
Annual
Subscribe to Yahoo Finance Plus Essential to download historical data

Income Statement

All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Breakdown
ttm
12/31/2021
12/31/2020
12/31/2019
12/31/2018
Total Revenue
0
0
0
0
0
Operating Expense
24,381
20,521
14,607
17,265
11,434
Operating Income
-24,381
-20,521
-14,607
-17,265
-11,434
Net Non Operating Interest Income Expense
-
-
-938.794
-
-
Other Income Expense
80
-85
-3,221
25.648
29.299
Pretax Income
-24,301
-20,606
-17,828
-17,240
-11,405
Tax Provision
0
0
0
0
-
Net Income Common Stockholders
-24,301
-20,606
-22,331
-17,240
-22,884
Diluted NI Available to Com Stockholders
-24,301
-20,606
-22,331
-17,240
-22,884
Basic EPS
-
-0.18
-1.97
-2.03
-5.50
Diluted EPS
-
-0.18
-1.97
-2.03
-5.50
Basic Average Shares
-
116,950
11,309
8,497
4,158
Diluted Average Shares
-
116,950
11,309
8,497
4,158
Total Operating Income as Reported
-24,381
-20,521
-14,607
-17,265
-11,434
Total Expenses
24,381
20,521
14,607
17,265
11,434
Net Income from Continuing & Discontinued Operation
-24,301
-20,606
-17,828
-17,240
-11,405
Normalized Income
-24,301
-20,606
-14,557
-17,240
-11,405
Net Interest Income
-
-
-938.794
-
-
EBIT
-24,381
-20,521
-14,607
-17,265
-11,434
EBITDA
-24,373
-
-
-
-
Reconciled Depreciation
8
23
46.52
52.789
44.197
Net Income from Continuing Operation Net Minority Interest
-24,301
-20,606
-17,828
-17,240
-11,405
Total Unusual Items Excluding Goodwill
-
-
-3,271
-
-
Total Unusual Items
-
-
-3,271
-
-
Normalized EBITDA
-24,373
-20,498
-11,290
-17,213
-11,390
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
Advertisement
Advertisement